x Those whose anti-HBs titres are below protective titre of 10 mIU/ml should repeat the 3-dose 
vaccine series or be evaluated for hepatitis B surface antigen (HBsAg) positivity. 
x Approximately 50% of individuals who did not respond to the Ô¨Å  rst series of the HBV vaccine 
respond to the second series of the vaccine. If the HCW does not respond to the second series, he/she should be labelled as a non-responder.
Post-exposure prophylaxis for HBVh
x If the source is HBV-positive: Appropriate and timely prophylaxis can prevent HBV 
infection and subsequent development of chronic infection or liver disease. The mainstay of PEP is hepatitis B vaccine, but in certain circumstances, hepatitis B immune globulin is recommended in addition to vaccine for added protection.